Jefferies Group LLC Ardelyx, Inc. Put Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $378,750 - $532,500	-75,000 Closed	0 $0
Q2 2020 Nov 02, 2020	BUY	$5.37 - $8.11 $402,750 - $608,250	75,000 New	75,000 $519,000
Q2 2020 Aug 14, 2020	SELL	$5.37 - $8.11 $214,800 - $324,400	-40,000 Closed	0 $0
Q1 2020 Nov 24, 2020	BUY	$4.35 - $8.79 $174,000 - $351,599	40,000 New	40,000 $231,000
Q1 2020 May 15, 2020	SELL	$4.35 - $8.79 $174,000 - $351,599	-40,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$2.15 - $6.28 $86,000 - $251,200	40,000 New	40,000 $188,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $796M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.